An Alu polymorphism intragenic to the TP53 gene

par Futreal, P.A., Barrett, J.C., Wiseman, R.W.
Publié 1991

Bcl10 is not a target for frequent mutation in human carcinomas

par Lambers, A R, Gumbs, C, Ali, S, Marks, J R, Iglehart, J D, Berchuck, A, Futreal, P A
Publié 1999

COSMIC 2005

par Forbes, S, Clements, J, Dawson, E, Bamford, S, Webb, T, Dogan, A, Flanagan, A, Teague, J, Wooster, R, Futreal, P A, Stratton, M R
Publié 2006

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

par Bamford, S, Dawson, E, Forbes, S, Clements, J, Pettett, R, Dogan, A, Flanagan, A, Teague, J, Futreal, P A, Stratton, M R, Wooster, R
Publié 2004

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

par Mahoney, C L, Choudhury, B, Davies, H, Edkins, S, Greenman, C, Haaften, G van, Mironenko, T, Santarius, T, Stevens, C, Stratton, M R, Futreal, P A
Publié 2009

The Catalogue of Somatic Mutations in Cancer (COSMIC)

par Forbes, S.A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J.W., Futreal, P.A., Stratton, M.R.
Publié 2008

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

par Lancaster, J. M., Carney, M. E., Gray, J., Myring, J., Gumbs, C., Sampson, J., Wheeler, D., France, E., Wiseman, R., Harper, P., Futreal, P. A.
Publié 1998

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

par Tonin, P N, Mes-Masson, A M, Futreal, P A, Morgan, K, Mahon, M, Foulkes, W D, Cole, D E, Provencher, D, Ghadirian, P, Narod, S A
Publié 1998

AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes

par Dicks, E., Teague, J. W., Stephens, P., Raine, K., Yates, A., Mattocks, C., Tarpey, P., Butler, A., Menzies, A., Richardson, D., Jenkinson, A., Davies, H., Edkins, S., Forbes, S., Gray, K., Greenman, C., Shepherd, R., Stratton, M. R., Futreal, P. A., Wooster, R.
Publié dans Bioinformatics (2007)

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

par Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic, A., Rance, R., McGee, C., Ellis, P., Mudie, L.J., Stephens, P.J., McLaren, S., Massie, C.E., Tarpey, P.S., Varela, I., Nik-Zainal, S., Davies, H.R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A.P., Teague, J.W., Baxter, E.J., Score, J., Galli, A., Della Porta, M.G., Travaglino, E., Groves, M., Tauro, S., Munshi, N.C., Anderson, K.C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A.J., Cross, N.C.P., Green, A.R., Futreal, P.A., Stratton, M.R., Campbell, P.J.
Publié 2011

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

par Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., de Macedo, M. Petaccia, Cotechini, T., Kumar, T., Chen, W. S., Reddy, S. M., Sloane, R. Szczepaniak, Galloway-Pena, J., Jiang, H., Chen, P. L., Shpall, E. J., Rezvani, K., Alousi, A. M., Chemaly, R. F., Shelburne, S., Vence, L. M., Okhuysen, P. C., Jensen, V. B., Swennes, A. G., McAllister, F., Sanchez, E. Marcelo Riquelme, Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J. L., Haydu, L. E., Burton, E. M., Gardner, J. M., Sirmans, E., Hu, J., Lazar, A. J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I. C., Hwu, W. J., Patel, S. P., Woodman, S. E., Amaria, R. N., Davies, M. A., Gershenwald, J. E., Hwu, P., Lee, J. E., Zhang, J., Coussens, L. M., Cooper, Z. A., Futreal, P. A., Daniel, C. R., Ajami, N. J., Petrosino, J. F., Tetzlaff, M. T., Sharma, P., Allison, J. P., Jenq, R. R., Wargo, J. A.
Publié dans Science (2017)